Henry Ikezi
Known title: 10% OwnerCIK: 0002092332
Henry Ikezi's purchase track record
Henry Ikezi has no open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 6/3/2026 | STI | $644K | +50.6% | pending | — |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| STI | ▼ Sell | Other | 214,037 | $0 | 6/5/2026 | View on chart |
| STI | ▲ Buy | Open Market | 2,000 | $72K | 6/5/2026 | View on chart |
| STI | ▲ Buy | Option Exercise | 214,037 | $662K | 6/5/2026 | View on chart |
| STI | ▼ Sell | Open Market | 13,500 | $606K | 6/5/2026 | View on chart |
| STI | ▼ Sell | Other | 214,037 | $0 | 6/5/2026 | View on chart |
| STI | ▼ Sell | Open Market | 192,437 | $7.2M | 6/5/2026 | View on chart |
| STI | ▲ Buy | Open Market | 23,000 | $567K | 6/4/2026 | View on chart |
| STI | ▼ Sell | Open Market | 188,951 | $4.4M | 6/4/2026 | View on chart |
| STI | ▲ Buy | Open Market | 1,000 | $5K | 6/3/2026 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
No recent news for STI
There were no company‑specific announcements or events reported for STI in the past week. The market activity for the day was driven by other names, such as Vicor, which saw a notable jump. STI's price remains within its 52‑week range and is near support at $6.35. No new catalysts are available at this time.
No recent news for STI. There were no company‑specific announcements or events reported for STI in the past week. The market activity for the day was driven by other names, such as Vicor, which saw a notable jump. STI's price remains within its 52‑week range and is near support at $6.35. No new catalysts are available at this time.